The role of molecular immunohematology in sickle cell disease

Transfusion and Apheresis Science

Volumn 44, Issue 1, 2011, Pages 73-79

  Chou, Stella T ^a   Westhoff, Connie M ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Laboratory of Immunohematology and Genomics   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP E ANTIGEN; EPITOPE; RHESUS C ANTIBODY; RHESUS D ANTIGEN; RHESUS E ANTIBODY; ALLOANTIBODY; BLOOD GROUP ANTIGEN; HEMOGLOBIN; HEMOGLOBIN S; RHESUS D ANTIBODY;

ALLELE; ALLOIMMUNIZATION; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; GENETIC ANALYSIS; GENOTYPE; HUMAN; IMMUNOPHENOTYPING; MOLECULAR GENETICS; PROTEIN VARIANT; SICKLE CELL ANEMIA; ANTIBODY PRODUCTION; BLOOD DONOR; BLOOD TRANSFUSION REACTION; CEREBROVASCULAR ACCIDENT; DNA DETERMINATION; GENE FREQUENCY; GENE LOCUS; GENETIC VARIABILITY; MOLECULAR BIOLOGY; MOLECULAR IMMUNOHEMATOLOGY; PATIENT SELECTION; PREVALENCE; PROTEIN EXPRESSION; TREATMENT INDICATION;

AFRICAN AMERICANS; ALLELES; ALLERGY AND IMMUNOLOGY; ANEMIA, SICKLE CELL; ARTIFACTS; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; DNA; GENOTYPE; HEMATOLOGY; HUMANS; ISOANTIBODIES; MOLECULAR DIAGNOSTIC TECHNIQUES; RH-HR BLOOD-GROUP SYSTEM;

EID: 79951683471     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2010.12.014     Document Type: Article

References (37)

1. Josephson C.D., Su L.L., Hillyer K.L., Hillyer C.D. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus Med Rev 2007, 21:118-133.
2. Ness P.M. To match or not to match: the question for chronically transfused patients with sickle cell anemia. Transfusion 1994, 34:558-560.
3. Afenyi-Annan A BN Transfusion practices for patients with sickle cell disease at a major academic medical center. Immunohematology 2006, 22:103-107.
4. Sesok-Pizzini D.A., Friedman D.F., Smith-Whitley K., Nance S.J. Transfusion support of patients with sickle cell disease at the Children's Hospital of Philadelphia. Immunohematology 2006, 22:121-125.
5. Ohene-Frempong K. Indications for red cell transfusion in sickle cell disease. Semin Hematol 2001, 38:5-13.
6. Adams R.J., Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005, 353:2769-2778.
7. Adams R.J., McKie V.C., Hsu L., et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998, 339:5-11.
8. Aygun B., Padmanabhan S., Paley C., Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002, 42:37-43.
9. Cox J.V., Steane E., Cunningham G., Frenkel E.P. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988, 148:2485-2489.
10. Vichinsky E.P., Earles A., Johnson R.A., Hoag M.S., Williams A., Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990, 322:1617-1621.
11. Tahhan H.R., Holbrook C.T., Braddy L.R., Brewer L.D., Christie J.D. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994, 34:562-569.
12. Vichinsky E.P., Luban N.L., Wright E., et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001, 41:1086-1092.
13. Rosse W.F., Gallagher D., Kinney T.R., et al. Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood 1990, 76:1431-1437.
14. Flickinger C. In search of red blood cells for alloimmunized patients with sickle cell disease. Immunohematology 2006, 22:136-142.
15. Win N., New H., Lee E., de la Fuente J. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion 2008, 48:1231-1238.
16. Talano J.A., Hillery C.A., Gottschall J.L., Baylerian D.M., Scott J.P. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003, 111:e661-665.
17. Ambruso D.R., Githens J.H., Alcorn R., et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987, 27:94-98.
18. Castro O., Sandler S.G., Houston-Yu P., Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002, 42:684-690.
19. Sosler S.D., Jilly B.J., Saporito C., Koshy M. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am J Hematol 1993, 43:103-106.
20. Osby M., Shulman I.A. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005, 129:190-193.
21. Daniels G. Human Blood Groups 2002, Blackwell Science, Cambridge, Mass. 2nd ed.
22. Wagner F.F., Flegel W.A. RHD gene deletion occurred in the Rhesus box. Blood 2000, 95:3662-3668.
23. Singleton B.K., Green C.A., Avent N.D., et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000, 95:12-18.
24. Wagner F.F., Gassner C., Muller T.H., Schonitzer D., Schunter F., Flegel W.A. Molecular basis of weak D phenotypes. Blood 1999, 93:385-393.
25. Shao C.P., Maas J.H., Su Y.Q., Kohler M., Legler T.J. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang 2002, 83:156-161.
26. Wagner T., Kormoczi G.F., Buchta C., et al. Anti-D immunization by DEL red blood cells. Transfusion 2005, 45:520-526.
27. Westhoff C.M. Review: the Rh blood group D antigen... dominant, diverse, and difficult. Immunohematology 2005, 21:155-163.
28. Beckers E.A., Porcelijn L., Ligthart P., et al. The RoHar antigenic complex is associated with a limited number of D epitopes and alloanti-D production: a study of three unrelated persons and their families. Transfusion 1996, 36:104-108.
29. Daniels G.L., Faas B.H., Green C.A., et al. The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion 1998, 38:951-958.
30. Vege S., Westhoff C.M. Molecular characterization of GYPB and RH in donors in the American Rare Donor Program. Immunohematology 2006, 22:143-147.
31. Reid M.E., Storry J.R., Issitt P.D., et al. Rh haplotypes that make e but not hrB usually make VS. Vox Sang 1997, 72:41-44.
32. Noizat-Pirenne F., Lee K., Pennec P.Y., et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002, 100:4223-4231.
33. Westhoff C. Molecular testing for transfusion medicine. Curr Opin Hematol 2006, 471-475.
34. Avent N.D., Martinez A., Flegel W.A., et al. The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion 2007, 47:40S-46S.
35. Hashmi G., Shariff T., Seul M., et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005, 45:680-688.
36. Hashmi G., Shariff T., Zhang Y., et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007, 47:736-747.
37. Anstee D.J. Red cell genotyping and the future of pretransfusion testing. Blood 2009, 114:248-256.